Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Viewers Cautioned on Televised Medical Talk Show Recommendations

By HospiMedica International staff writers
Posted on 05 Jan 2015
A new study warns that the public should be skeptical of recommendations made on mainstream television medical talk shows, as they often lack adequate evidence or are contradicted by the best available evidence. More...


Researchers at the University of Alberta (Edmonton, Canada) chose two internationally syndicated medical talk shows to analyze: The Dr. Oz Show and The Doctors. Each show was recorded every day from January 2013 to April 2013. The researchers then randomly selected 40 episodes of each show and had two team members watch every episode independently, recording topics, recommendations made, and who was making the recommendations. Two other researchers also watched the episodes and review the recommendations, focusing on benefits mentioned, if the magnitude of the benefit was quantified, costs, and conflict of interest.

The researchers found evidence to support 54% of the 160 randomly selected recommendations (80 from each show). For The Dr. Oz Show, evidence supported 46%, contradicted 15%, and was not found for 39%. For The Doctors, evidence supported 63%, contradicted 14%, and was not found for 24%. Believable or somewhat believable evidence supported 33% of the recommendations on The Dr. Oz Show and 53% on The Doctors. The most common recommendation category on The Dr. Oz Show was dietary advice (39%) and on The Doctors was to consult a healthcare provider (18%).

Further findings included a specific benefit for 43% and 41% of the recommendations made on the shows respectively. The magnitude of benefit was described for 17% of the recommendations on The Dr. Oz Show and 11% on The Doctors. Disclosure of potential conflicts of interest accompanied only 0.4% of recommendations for both shows. The study was published in the Christmas edition of the British Medical Journal (BMJ), which was dedicated to media studies.

“Some patients come in and say 'I heard on Dr. Oz yesterday that we should all be doing this.' And then we're left scrambling in our office to try to find answers. It got us reflecting, what's being said there? What kinds of things are being recommended and what kind of information is being provided?” said lead author Christina Korownyk, MD, an associate professor in the department of family medicine. “Frequently you're not getting enough information and without doing the research you won't know if it's supported by evidence or not; the research supporting any of these recommendations is frequently absent, contradictory, or of poor quality.”

Related Links:

University of Alberta



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.